3 Australian Penny Stocks Backed By Strong Financial Health

Simply Wall St.

Jul 31

Penny stocks often get attention for the wrong reasons, yet the Financially Fit Penny Stocks screener focuses on something much simpler. It highlights companies trading below 5 that also show solid ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/2656139889"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2656139889\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2656139889?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/3021000-choice1-main-header/1585186644732","is_english":true,"pubTime":"2026-07-31 23:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2656139889","market":"hk","top_or_hot":-1,"title":"3 Australian Penny Stocks Backed By Strong Financial Health","media":"Simply Wall St.","content":"<div>\n<p>Penny stocks often get attention for the wrong reasons, yet the Financially Fit Penny Stocks screener focuses on something much simpler. It highlights companies trading below 5 that also show solid ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/capital-goods/asx-dro/droneshield-shares/news/3-australian-penny-stocks-backed-by-strong-financial-health\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Australian Penny Stocks Backed By Strong Financial Health</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Australian Penny Stocks Backed By Strong Financial Health\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-31 23:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/au/capital-goods/asx-dro/droneshield-shares/news/3-australian-penny-stocks-backed-by-strong-financial-health><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Penny stocks often get attention for the wrong reasons, yet the Financially Fit Penny Stocks screener focuses on something much simpler. It highlights companies trading below 5 that also show solid ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/capital-goods/asx-dro/droneshield-shares/news/3-australian-penny-stocks-backed-by-strong-financial-health\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"QFN.AU","symbol_name":"BetaShares Australian Fincls Sect ETF","start_time":0,"source_url":"https://simplywall.st/stocks/au/capital-goods/asx-dro/droneshield-shares/news/3-australian-penny-stocks-backed-by-strong-financial-health","article_id":"2656139889","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/3021000-choice1-main-header/1585186644732"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/capital-goods/asx-dro/droneshield-shares/news/3-australian-penny-stocks-backed-by-strong-financial-health","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2656139889","pubTimestamp":1785511514,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Penny stocks often get attention for the wrong reasons, yet the Financially Fit Penny Stocks screener focuses on something much simpler. It highlights companies trading below 5 that also show solid financial health. In a world where central banks are weighing inflation against growth, energy prices influence rate expectations, and economic signals vary by region, that kind of discipline matters. This approach provides exposure to earlier stage opportunities without relying solely on hope...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"QFN.AU":"BetaShares Australian Fincls Sect ETF","STW.AU":"SPDR® S&P/ASX 200 ETF","BBOZ.AU":"BETASHARES AUSTRALIAN STRONG BEAR (HEDGE FUND)","IOZ.AU":"iShares Core S&P/ASX 200","QRE.AU":"BetaShares Australian Res Sect ETF","BK7115":"航天航空与国防","ZYAU.AU":"Etfs S&p/asx 300 High Yield Plus Etf","SLF.AU":"SPDR S&P/ASX 200 LISTED PROP","VAP.AU":"VANGUARD AU PROP SEC IDX ETF","BK7067":"生物科技","VAS.AU":"VANGUARD AUST SHARES IDX ETF","DACE.AU":"DIMENSIONAL AUST CORE EQ","BEAR.AU":"BETASHARES AUS EQ BEAR HF","BK7501":"新冠治疗股","SIG.AU":"SIGMA HEALTHCARE LTD","OZF.AU":"SPDR S&P/ASX 200 FINANCIALS","XAO.AU":"标普/澳交所 普通股指数","EIGA.AU":"EINVEST INCOME GENERATOR FD","IMLC.AU":"INV MUTUAL CONC AUS SHAR ETF","OZR.AU":"SPDR S&P/ASX 200 RESOURCES F","DRO.AU":"DRONESHIELD LTD","IIGF.AU":"Intelligent Investor Australian Equity Growth Fund (Managed Fund)","XJO.AU":"标普/澳交所 200指数","BK7103":"保健护理产品经销商","XKO.AU":"标普/澳交所 300指数","IISV.AU":"INTELL INV SELVAL SHR FD MF","MSB.AU":"MESOBLAST LTD","BK7508":"医药生物股","E200.AU":"SPDR S&P/ASX 200 ESG FUND","GEAR.AU":"BETASHARES GEARED AUS EQTY F","GIVE.AU":"PERPETUAL ESG AU SHR EQMF"},"translate_title":"3 只拥有强劲财务状况的澳大利亚细价股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZYAU.AU":0.6,"DRO.AU":1,"IISV.AU":0.6,"XAO.AU":1.5,"VAS.AU":0.6,"EIGA.AU":0.6,"VAP.AU":0.6,"XKO.AU":1.5,"IIGF.AU":0.6,"SIG.AU":1,"MSB.AU":1,"IMLC.AU":0.6,"QRE.AU":0.6,"IOZ.AU":0.6,"E200.AU":0.6,"OZF.AU":0.6,"QFN.AU":0.6,"DACE.AU":0.6,"BEAR.AU":0.6,"XJO.AU":1.5,"GIVE.AU":0.6,"BBOZ.AU":0.6,"GEAR.AU":0.6,"OZR.AU":0.6,"STW.AU":0.6,"SLF.AU":0.6},"content_text":"Penny stocks often get attention for the wrong reasons, yet the Financially Fit Penny Stocks screener focuses on something much simpler. It highlights companies trading below 5 that also show solid financial health. In a world where central banks are weighing inflation against growth, energy prices influence rate expectations, and economic signals vary by region, that kind of discipline matters. This approach provides exposure to earlier stage opportunities without relying solely on hope. This article walks through 3 stocks from the screener and shows how they fit this financial health driven approach. AdvertisementDroneShield (ASX:DRO) Overview: DroneShield is a Sydney based defence technology company that builds hardware and software to detect and disable hostile drones for customers including militaries, security agencies and critical infrastructure operators around the world. Operations: DroneShield currently generates about A$216.8 million in revenue, all from its Aerospace & Defense activities across the USA and the rest of the world. Market Cap: A$1.6b DroneShield operates in a segment of defence spending that is receiving continued attention, as militaries, governments and major event organisers look for reliable ways to detect and counter drones. The company has moved beyond one-off wins and is building repeat institutional relationships, supported by contracts such as the recent A$23.2 million European defence deals and deployments tied to major events like the FIFA World Cup 2026. Current valuation is high relative to estimated cash flows and ROE remains low. With an ASIC investigation ongoing and funding that relies on external borrowing, investors may wish to focus on how consistently DroneShield converts its order book into profitable, longer term contracts. DroneShield’s accelerating contract wins raise a clear question: Is the current price already baking in the story, or is the real inflection still ahead? Get the full picture in the analysis report for DroneShield DRO Discounted Cash Flow as at Jul 2026 Sigma Healthcare (ASX:SIG) Overview: Sigma Healthcare is a long established Australian pharmacy group that supplies medicines and health products to community pharmacies, franchises retail brands like Chemist Warehouse, Amcal and Discount Drug Stores, and provides logistics and support services to pharmaceutical manufacturers, both in store and online. Operations: Sigma Healthcare generates about A$9.5b in revenue, largely from its Healthcare operations, with A$9.2b from Australia and A$389.8m from international markets. Market Cap: A$34.0b Investors looking at Sigma Healthcare can see a large scale distributor and franchisor with earnings and revenue growth forecasts that sit ahead of the wider Australian market, yet the stock trades only slightly below estimated fair value. The story is not one way, though. Net margins have narrowed from 11.5% to 6.3%, the P/E is high relative to peers and all funding relies on external borrowing, which raises questions about resilience if conditions tighten. A relatively new and less independent board adds another layer for you to weigh. The interest comes from whether this mix of solid growth and execution risk is being priced correctly, especially after Sigma stepped back from the Boots UK talks to focus on its core opportunities. Sigma Healthcare appears to be a large, steady operator; however, its combination of a high P/E ratio, thinner margins and reliance on external borrowing suggests a more complex story than the headline numbers indicate. See how the market is weighing that balance in the 3 key rewards and 1 important warning sign ASX:SIG P/E Ratio as at Jul 2026 Mesoblast (ASX:MSB) Overview: Mesoblast is a Melbourne based biotech that develops regenerative cell therapies using mesenchymal lineage cells to treat severe inflammatory, cardiovascular and pain conditions, including pediatric and adult graft versus host disease, chronic low back pain and chronic heart failure. Operations: Mesoblast generates about US$65.4 million in revenue from developing its cell technology platform for commercialization. Market Cap: A$2.7b Mesoblast stands out in the penny stock space because it already has an FDA approved cell therapy, Ryoncil, together with more than 1,100 patents, commercial scale manufacturing and growing product revenue in a sector where many peers are still pre commercial. The stock trades below some fair value estimates, but the company is still loss making and relies on higher risk external borrowing to fund an extensive pipeline. Much of the long term story hinges on label expansions, new indications and regulatory decisions in large markets like chronic low back pain and heart failure, so a key consideration is how much of that potential is already reflected in the share price. Mesoblast already has an FDA approved therapy and large patent estate, yet the stock still trades as if the story is unfinished. See how the market is framing that gap in the full narrative for Mesoblast MSB Discounted Cash Flow as at Jul 2026 The three stocks here are just a starting point, and the full Financially Fit Penny Stocks screener surfaces 404 more companies that pair low share prices with balance sheets and cash flows that help support their stories. Use Simply Wall St to identify, analyze and filter for the exact catalysts and narratives that matter most to you, so you can focus on the opportunities you find most compelling in this corner of the market. Take Control of Your Investment Journey  If Mesoblast or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen.\n            Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates.\n            Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives.\n            By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.\n         Curious About What You Might Be Missing Fresh ideas do not stay under the radar for long. Stocks can move from quiet to breakout while you wait. Check these curated lists before momentum starts flying and consider acting promptly.  Spot companies with strong cash generation and balance sheets before they gain wider attention by scanning this curated group of 7 high quality undervalued stocks. Tap into structural shifts in power and grid technology by reviewing a focused set of infrastructure businesses in the 35 power grid technology and infrastructure stocks. Focus on consistent cash payers with higher yields by working through a hand picked group of 4 dividend fortresses.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}